¿Ü±¹µµ¼
´ëÇб³Àç/Àü¹®¼Àû
ÀǾàÇа£È£°è¿
2013³â 9¿ù 9ÀÏ ÀÌÈÄ ´©Àû¼öÄ¡ÀÔ´Ï´Ù.
Á¤°¡ |
120,000¿ø |
---|
120,000¿ø
3,600P (3%Àû¸³)
ÇÒÀÎÇýÅÃ | |
---|---|
Àû¸³ÇýÅà |
|
|
|
Ãß°¡ÇýÅÃ |
|
À̺¥Æ®/±âȹÀü
¿¬°üµµ¼
»óÇ°±Ç
ÀÌ»óÇ°ÀÇ ºÐ·ù
¸ñÂ÷
Introduction; List of icons; 1. acamprosate; 2. agomelatine; 3. alprazolam; 4. amisulpride; 5. amitriptyline; 6. amoxapine; 7. amphetamin (d); 8. amphetamine (d, l); 9. aripiprazole; 10. armodafinil; 11. asenapine; 12. atomoxetine; 13. benztropine; 14. blonanserin; 15. bremelanotide; 16. brexanolone; 17. brexpiprazole; 18. buprenorphine; 19. bupropion; 20. buspirone; 21. caprylidene; 22. carbamazepine; 23. cariprazine; 24. chlordiazepoxide; 25. chlorpromazine; 26. citalopram; 27. clomipramine; 28. clonazepam; 29. clonidine; 30. clorazepate; 31. clozapine; 32. cyamemazine; 33. desipramine; 34. desvenlafaxine; 35. deutetrabenazine; 36. dextromethorphan; 37. diazepam; 38. diphenhydramine; 39. disulfiram; 40. donepezil; 41. dothiepin; 42. doxepin; 43. duloxetine; 44. escitalopram; 45. esketamine; 46. estazolam; 47. eszopiclone; 48. flibanserin; 49. flumazenil; 50. flunitrazepam; 51. fluoxetine; 52. flupenthixol; 53. fluphenazine; 54. flurazepam; 55. fluvoxamine; 56. gabapentin; 57. galantamine; 58. guanfacine; 59. haloperidol; 60. hydroxyzine; 61. iloperidone; 62. imipramine; 63. isocarboxazid; 64. ketamine; 65. lamotrigine; 66. levetiracetam; 67. lemborexant; 68. levomilnacipran; 69. lisdexamfetamine; 70. lithium; 71. lofexidine; 72. lofepramine; 73. loflazeptate; 74. lorazepam; 75. loxapine; 76.lumateperone; 77. lurasidone; 78. maprotiline; 79. memantine; 80.methylfolate (l); 81. methylphenidate (d); 82. methylphenidate (d, l); 83. mianserin; 84. midazolam; 85. milnacipran; 86. mirtazapine; 87. moclobemide; 88. modafinil; 89. molindone; 90. nalmefene; 91. naltrexone; 92. naltrexone-bupropion; 93. nefazodone; 94. nortriptyline; 95. olanzapine; 96. oxazepam; 97. oxcarbazepine; 98. paliperidone; 99. paroxetine; 100. perospirone; 101. perphenazine; 102. phenelzine; 103. phentermine-topiramate; 104. pimavanserin; 105. pimozide; 106. pipothiazine; 107. pitolisant; 108. prazosin; 109. pregabalin; 110. propranolol; 111. protriptyline; 112. quazepam; 113. quetiapine; 114. ramelteon; 115. reboxetine; 116. risperidone; 117. rivastigmine; 118. selegiline; 119. sertindole; 120. sertraline; 121. sildenafil; 122. sodium oxybate; 123. solriamfetol; 124. sulpiride; 125.suvorexant; 126. tasimelteon; 127. temazepam; 128. thioridazine; 129. thiothixene; 130. tiagabine; 131. tianeptine; 132. topiramate; 133. tranylcypromine; 134. trazodone; 135. triazolam; 136. trifluoperazine; 137. trihexyphenidyl; 138. triiodothyronine; 139. trimipramine; 140. valbenazine; 141. valproate; 142. varenicline; 143. venlafaxine; 144. vilazodone; 145. vortioxetine; 146. zaleplon; 147. ziprasidone; 148. zolpidem; 149. zonisamide; 150. zopiclone; 151. zotepine; 152. zuclopenthixol; Index by drug name; Index by use; Index by class; Abbreviation
Ã¥¼Ò°³
This fully updated Seventh Edition, includes nine new drugs, and remains the indispensable guide for all mental health prescribers.
With the range of psychotropic drugs expanding and the usages of existing medications diversifying, we are pleased to present the Seventh Edition of the world's best-selling formulary in psychopharmacology. The new edition features nine new compounds as well as information about several new formulations of existing drugs. Many important new indications are covered for existing drugs, as are updates to the profiles of the entire content and collection, including new injectable and transdermal formulations, as well as updated warnings and indications. The Pearls have all been refreshed and the antipsychotics section has been completely revised. With its easy-to-use, full-colour template-driven navigation system, Prescriber's Guide combines evidence-based data with clinically informed advice to support everyone who is prescribing in the field of mental health.
ÀúÀÚ¼Ò°³
»ý³â¿ùÀÏ | - |
---|
ÇØ´çÀÛ°¡¿¡ ´ëÇÑ ¼Ò°³°¡ ¾ø½À´Ï´Ù.
ÀúÀÚÀÇ ´Ù¸¥Ã¥
Àüüº¸±âStahl's Essential Psychopharmacology
ÁÖ°£·©Å·
´õº¸±â»óÇ°Á¤º¸Á¦°ø°í½Ã
À̺¥Æ® ±âȹÀü
´ëÇб³Àç/Àü¹®¼Àû ºÐ¾ß¿¡¼ ¸¹Àº ȸ¿øÀÌ ±¸¸ÅÇÑ Ã¥
ÆǸÅÀÚÁ¤º¸
»óÈ£ |
(ÁÖ)±³º¸¹®°í |
---|---|
´ëÇ¥ÀÚ¸í |
¾Èº´Çö |
»ç¾÷ÀÚµî·Ï¹øÈ£ |
102-81-11670 |
¿¬¶ôó |
1544-1900 |
ÀüÀÚ¿ìÆíÁÖ¼Ò |
callcenter@kyobobook.co.kr |
Åë½ÅÆǸž÷½Å°í¹øÈ£ |
01-0653 |
¿µ¾÷¼ÒÀçÁö |
¼¿ïƯº°½Ã Á¾·Î±¸ Á¾·Î 1(Á¾·Î1°¡,±³º¸ºôµù) |
±³È¯/ȯºÒ
¹ÝÇ°/±³È¯ ¹æ¹ý |
¡®¸¶ÀÌÆäÀÌÁö > Ãë¼Ò/¹ÝÇ°/±³È¯/ȯºÒ¡¯ ¿¡¼ ½Åû ¶Ç´Â 1:1 ¹®ÀÇ °Ô½ÃÆÇ ¹× °í°´¼¾ÅÍ(1577-2555)¿¡¼ ½Åû °¡´É |
---|---|
¹ÝÇ°/±³È¯°¡´É ±â°£ |
º¯½É ¹ÝÇ°ÀÇ °æ¿ì Ãâ°í¿Ï·á ÈÄ 6ÀÏ(¿µ¾÷ÀÏ ±âÁØ) À̳»±îÁö¸¸ °¡´É |
¹ÝÇ°/±³È¯ ºñ¿ë |
º¯½É ȤÀº ±¸¸ÅÂø¿À·Î ÀÎÇÑ ¹ÝÇ°/±³È¯Àº ¹Ý¼Û·á °í°´ ºÎ´ã |
¹ÝÇ°/±³È¯ ºÒ°¡ »çÀ¯ |
·¼ÒºñÀÚÀÇ Ã¥ÀÓ ÀÖ´Â »çÀ¯·Î »óÇ° µîÀÌ ¼Õ½Ç ¶Ç´Â ÈÑ¼ÕµÈ °æ¿ì ·¼ÒºñÀÚÀÇ »ç¿ë, Æ÷Àå °³ºÀ¿¡ ÀÇÇØ »óÇ° µîÀÇ °¡Ä¡°¡ ÇöÀúÈ÷ °¨¼ÒÇÑ °æ¿ì ·º¹Á¦°¡ °¡´ÉÇÑ »óÇ° µîÀÇ Æ÷ÀåÀ» ÈѼÕÇÑ °æ¿ì ·½Ã°£ÀÇ °æ°ú¿¡ ÀÇÇØ ÀçÆǸŰ¡ °ï¶õÇÑ Á¤µµ·Î °¡Ä¡°¡ ÇöÀúÈ÷ °¨¼ÒÇÑ °æ¿ì ·ÀüÀÚ»ó°Å·¡ µî¿¡¼ÀÇ ¼ÒºñÀÚº¸È£¿¡ °üÇÑ ¹ý·üÀÌ Á¤ÇÏ´Â ¼ÒºñÀÚ Ã»¾àöȸ Á¦ÇÑ ³»¿ë¿¡ ÇØ´çµÇ´Â °æ¿ì |
»óÇ° Ç°Àý |
°ø±Þ»ç(ÃâÆÇ»ç) Àç°í »çÁ¤¿¡ ÀÇÇØ Ç°Àý/Áö¿¬µÉ ¼ö ÀÖÀ½ |
¼ÒºñÀÚ ÇÇÇغ¸»ó |
·»óÇ°ÀÇ ºÒ·®¿¡ ÀÇÇÑ ±³È¯, A/S, ȯºÒ, Ç°Áúº¸Áõ ¹× ÇÇÇغ¸»ó µî¿¡ °üÇÑ »çÇ×Àº¼ÒºñÀÚºÐÀïÇØ°á ±âÁØ (°øÁ¤°Å·¡À§¿øȸ °í½Ã)¿¡ ÁØÇÏ¿© ó¸®µÊ ·´ë±Ý ȯºÒ ¹× ȯºÒÁö¿¬¿¡ µû¸¥ ¹è»ó±Ý Áö±Þ Á¶°Ç, ÀýÂ÷ µîÀº ÀüÀÚ»ó°Å·¡ µî¿¡¼ÀǼҺñÀÚ º¸È£¿¡ °üÇÑ ¹ý·ü¿¡ µû¶ó ó¸®ÇÔ |
(ÁÖ)ÀÎÅÍÆÄÅ©Ä¿¸Ó½º´Â ȸ¿ø´ÔµéÀÇ ¾ÈÀü°Å·¡¸¦ À§ÇØ ±¸¸Å±Ý¾×, °áÁ¦¼ö´Ü¿¡ »ó°ü¾øÀÌ (ÁÖ)ÀÎÅÍÆÄÅ©Ä¿¸Ó½º¸¦ ÅëÇÑ ¸ðµç °Å·¡¿¡ ´ëÇÏ¿©
(ÁÖ)KGÀ̴Ͻýº°¡ Á¦°øÇÏ´Â ±¸¸Å¾ÈÀü¼ºñ½º¸¦ Àû¿ëÇÏ°í ÀÖ½À´Ï´Ù.
¹è¼Û¾È³»
±³º¸¹®°í »óÇ°Àº Åùè·Î ¹è¼ÛµÇ¸ç, Ãâ°í¿Ï·á 1~2Àϳ» »óÇ°À» ¹Þ¾Æ º¸½Ç ¼ö ÀÖ½À´Ï´Ù.
Ãâ°í°¡´É ½Ã°£ÀÌ ¼·Î ´Ù¸¥ »óÇ°À» ÇÔ²² ÁÖ¹®ÇÒ °æ¿ì Ãâ°í°¡´É ½Ã°£ÀÌ °¡Àå ±ä »óÇ°À» ±âÁØÀ¸·Î ¹è¼ÛµË´Ï´Ù.
±ººÎ´ë, ±³µµ¼Ò µî ƯÁ¤±â°üÀº ¿ìü±¹ Åù踸 ¹è¼Û°¡´ÉÇÕ´Ï´Ù.
¹è¼Ûºñ´Â ¾÷ü ¹è¼Ûºñ Á¤Ã¥¿¡ µû¸¨´Ï´Ù.